Health
Daiichi Sankyo says it has begun producing AstraZeneca’s COVID-19 vaccine in Japan – TheChronicleHerald.ca
TOKYO (Reuters) – Daiichi Sankyo Co said on Friday it had begun the production of AstraZeneca Plc’s COVID-19 vaccine in Japan. The drugmaker said in a release it…
TOKYO (Reuters) – Daiichi Sankyo Co said on Friday it had begun the production of AstraZeneca Plc’s COVID-19 vaccine in Japan.
The drugmaker said in a release it will prepare the vaccine in Japan, including vial filling and packaging, using the bulk solution provided by AstraZeneca.
The Japanese government has already arranged to buy 120 million doses of AstraZeneca’s vaccine, enough for 60 million people. Most of the doses will be made in Japan by Daiichi Sankyo, JCR Pharma and other local partners.
…
-
Noosa News19 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News21 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News18 hours agoFranz Ferdinand: Australian Tour 2025
-
Business18 hours agoHow these 5 ASX 200 stocks are smashing the benchmark this week